Table 4

Four active peptides against cancer cells used in the case study

Peptide IDPeptide sequencePredictionBase SHAP valueOutput SHAP values
Helical1FLWIKLGKLAGAVLKLILGLKKVVACP0.390.69
AmphiArc1KWVKKVHNWLRRWIKVFEALFG0.67
AmphiArc2KIFKKFKTIIKKVWRIFGRF0.70
Gradient2AWLKRIKKFLKALFWVWVW0.68
Peptide IDPeptide sequencePredictionBase SHAP valueOutput SHAP values
Helical1FLWIKLGKLAGAVLKLILGLKKVVACP0.390.69
AmphiArc1KWVKKVHNWLRRWIKVFEALFG0.67
AmphiArc2KIFKKFKTIIKKVWRIFGRF0.70
Gradient2AWLKRIKKFLKALFWVWVW0.68
Table 4

Four active peptides against cancer cells used in the case study

Peptide IDPeptide sequencePredictionBase SHAP valueOutput SHAP values
Helical1FLWIKLGKLAGAVLKLILGLKKVVACP0.390.69
AmphiArc1KWVKKVHNWLRRWIKVFEALFG0.67
AmphiArc2KIFKKFKTIIKKVWRIFGRF0.70
Gradient2AWLKRIKKFLKALFWVWVW0.68
Peptide IDPeptide sequencePredictionBase SHAP valueOutput SHAP values
Helical1FLWIKLGKLAGAVLKLILGLKKVVACP0.390.69
AmphiArc1KWVKKVHNWLRRWIKVFEALFG0.67
AmphiArc2KIFKKFKTIIKKVWRIFGRF0.70
Gradient2AWLKRIKKFLKALFWVWVW0.68
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close